Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer 1988 2019

2019

Daratumumab for treatment of blastic plasmacytoid dendritic cell neoplasm A single-case report

Iversen, K. F., Holdgaard, P. C., Preiss, B., Nyvold, C. G. & Plesner, T., sep. 2019, I : Haematologica. 104, 9, s. e432-e433

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Daratumumab plus lenalidomide and dexamethasone for untreated Myeloma

MAIA Trial Investigators, 30. maj 2019, I : New England Journal of Medicine. 380, 22, s. 2104-2115

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Control Groups
Confidence Intervals
Neutropenia
daratumumab
Lymphopenia

Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study

Plesner, T., Arkenau, H. T., Gay, F., Minnema, M. C., Boccadoro, M., Moreau, P., Cavenagh, J., Perrot, A., Laubach, J. P., Krejcik, J., Ahmadi, T., de Boer, C., Chen, D., Chiu, C., Schecter, J. M. & Richardson, P. G., aug. 2019, I : British Journal of Haematology. 186, 3, s. e35-e39

Publikation: Bidrag til tidsskriftLetterForskningpeer review

77 Downloads (Pure)

High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action

Adams, H. C., Stevenaert, F., Krejcik, J., Van der Borght, K., Smets, T., Bald, J., Abraham, Y., Ceulemans, H., Chiu, C., Vanhoof, G., Usmani, S. Z., Plesner, T., Lonial, S., Nijhof, I., Lokhorst, H. M., Mutis, T., van de Donk, N. W. C. J., Sasser, A. K. & Casneuf, T., 1. mar. 2019, I : Cytometry. Part A. 95, 3, s. 279-289

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Granzymes
Flow Cytometry
Population
Immunophenotyping
Plasma Cells

Subcutaneous Delivery of Daratumumab in Relapsed or Refractory Multiple Myeloma

Usmani, S. Z., Nahi, H., Mateos, M-V., van de Donk, N. W. C. J., Chari, A., Kaufman, J. L., Moreau, P., Oriol, A., Plesner, T., Benboubker, L., Hellemans, P., Masterson, T., Clemens, P. L., Luo, M., Liu, K. & San Miguel, J., 22. aug. 2019, I : Blood. 134, 8, s. 668-677

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Hyaluronoglucosaminidase
Pharmacokinetics
Enzymes
daratumumab
Safety

“Fine-tuning cytoreduction in resistant multiple myeloma - progress here, too”?

Plesner, T., nov. 2019, I : British Journal of Haematology. 187, 3, s. 275-276

Publikation: Bidrag til tidsskriftLederForskningpeer review

2018
83 Downloads (Pure)

Daratumumab for the treatment of multiple myeloma

Plesner, T. & Krejcik, J., 4. jun. 2018, I : Frontiers in Immunology. 9, 6 s., 1228.

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Åben adgang
Fil
daratumumab

EUROPEAN POST-APPROVAL SAFETY STUDY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SAFETY IN PATIENTS TREATED WITH POMALIDOMIDE IN A REAL-WORLD SETTING

Schmidt-Hieber, M., Abildgaard, N., Gamberi, B., Di Raimondo, F., Ramirez Payer, A., Kyriakou, C., Froen, H. F., Izarra, A. I., Kueenburg, E. ., Di Micco, A., Rosettani, B., Bacon, P., Atiba-Davies, M. & Plesner, T., 15. jun. 2018, I : EHA Learning Center.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

EUROPEAN POST-APPROVAL SAFETY STUDY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SAFETY IN PATIENTS TREATED WITH POMALIDOMIDE IN A REAL-WORLD SETTING

Schmidt-Hieber, M., Abildgaard, N., Gamberi, B., Di Raimondo, F., Ramirez Payer, A., Kyriakou, C., Froen, H. F., Izarra, A. I., Kueenburg, E. ., Di Micco, A., Rosettani, B., Bacon, P., Atiba-Davies, M. & Plesner, T., 15. jun. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Inclusion body myositis and T cell large granular lymphocytic leucaemia: An underestimated coexistence of two severe disorders

Morillon, M., Iversen, K. F., korsgaard, S., Plesner, T. & Diederichsen, L. C. P. R., 1. sep. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

70 Downloads (Pure)

Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma

Yan, X., Clemens, P. L., Puchalski, T., Lonial, S., Lokhorst, H., Voorhees, P. M., Usmani, S., Richardson, P. G., Plesner, T., Liu, K., Orlowski, R. Z., Losic, N., Jansson, R., Ahmadi, T., Lantz, K., Ruixo, J. J. P., Zhou, H. & Xu, X. S., 2018, I : Clinical Pharmacokinetics. 57, 4, s. 529-538

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
daratumumab
Albumins
Odds Ratio
Confidence Intervals
Kidney

Safety in Patients with Multiple Myeloma Treated with Pomalidomide in a Real-World Setting According to Last Prior Treatment: A European Post-Authorization Safety Study

Abildgaard, N., Vekemans, M-C., Gamberi, B., Di Raimondo, F., Ramirez Payer, A., Kyriakou, C., Kentos, A., Kueenburg, E. ., Di Micco, A., Rosettani, B., Bacon, P., Atiba-Davies, M. & Plesner, T., 2. dec. 2018.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Safety in Patients with Multiple Myeloma Treated with Pomalidomide in a Real-World Setting According to Last Prior Treatment: A European Post-Authorization Safety Study

Abildgaard, N., Vekemans, M-C., Gamberi, B., Di Raimondo, F., Ramirez Payer, A., Kyriakou, C., Kentos, A., Kueenburg, E. ., Di Micco, A., Rosettani, B., Bacon, P., Atiba-Davies, M. & Plesner, T., 2. dec. 2018, I : Blood. 132, Suppl.1, s. 3286 1 s.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

2017
124 Downloads (Pure)

Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma

Xu, X. S., Yan, X., Puchalski, T., Lonial, S., Lokhorst, H. M., Voorhees, P. M., Plesner, T., Liu, K., Khan, I., Jansson, R., Ahmadi, T., Perez Ruixo, J. J., Zhou, H. & Clemens, P. L., 2017, I : Clinical Pharmacology & Therapeutics. 101, s. 721-724

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Pharmacokinetics
Pharmaceutical Preparations
daratumumab

Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma

Casneuf, T., Xu, X. S., Adams, H. C., Axel, A. E., Chiu, C., Khan, I., Ahmadi, T., Yan, X., Lonial, S., Plesner, T., Lokhorst, H. M., van de Donk, N. W. C. J., Clemens, P. L. & Sasser, A. K., 2017, I : Blood Advances. 1, 23, s. 2105-2114

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Safety
daratumumab
Infection Control
Clinical Trials
Neoplasms

Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study

Sezer, O., Beksac, M., Hajek, R., Sucak, G., Cagirgan, S., Linkesch, W., Meltem Akay, O., Gülbas, Z., Nahi, H., Plesner, T., Snowden, J. A., Timurağaoğlu, A., Dechow, T., Lang, A., Tuğlular, T., Drach, J., Armbrecht, G., Potamianou, A., Couturier, C., Olie, R. A. & 3 flere, Feys, C., Allietta, N. & Terpos, E., jul. 2017, I : British Journal of Haematology. 178, 1, s. 61-71

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Observation
Peripheral Nervous System Diseases
Bone Density
Disease-Free Survival
Bortezomib

FDG PET/CT in multiple myeloma: changed FDG uptake in the brain of patients receiving high dose chemotherapy

Østergaard, B., Shamchi, S. P., Taghvaei, R., Zirakchian, M. Z., Raynor, W., Nielsen, A. L., Holdgaard, P. C., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 2017, I : European Journal of Nuclear Medicine and Molecular Imaging. 44, 2 Suppl., s. 483-484 EP-0127.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

FDG PET/CT in multiple myeloma: changed FDG uptake in the brain of patients receiving high dose chemotherapy

Østergaard, B., Shamchi, S. P., Taghvaei, R., Zirakchian, M. Z., Raynor, W., Nielsen, A. L., Holdgaard, P. C., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 21. okt. 2017, s. 483-484.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

FDG-PET/CT in multiple myeloma: dual time point imaging results can predict response to treatment in patients recieving high dose chemotherapy

Østergaard, B., Taghvaei, R., Nielsen, A. L., Zirakchian, M. Z., Raynor, W., Asmussen, J. T., Holdgaard, P. C., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 10. dec. 2017, s. 483. 1 s.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

FDG-PET/CT in multiple myeloma: dual time point imaging results can predict response to treatment in patients recieving high dose chemotherapy

Østergaard, B., Taghvaei, R., Nielsen, A. L., Zirakchian, M. Z., Raynor, W., Asmussen, J. T., Holdgaard, P. C., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 2017, I : European Journal of Nuclear Medicine and Molecular Imaging. 44, 2 Suppl., s. 483 1 s., WHO 2016 C.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group

Stege, C. A. M., van der Holt, B., Mellqvist, U-H., Levin, M-D., Salomo, M., Abildgaard, N., Bos, G., Visser-Wisselaar, H., Hansson, M., van der Velden, A., Deenik, W., Gruber, A., Coenen, J. L. L. M., Plesner, T., Klein, S., Tanis, B., Szatkowski, D. L., Brouwer, R., Westerman, M., Leijs, M. B. & 11 flere, Sinnige, H., Haukås, E., van der Hem, K., Durian, M. F., Mattijssen, V., Gimsing, P., Van De Donk, N. WCJ., Stevens-Kroef, M., Sonneveld, P., Waage, A. & Zweegman, S., 2017, I : Blood. 130, Suppl. 1, 3146.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group

Stege, C. A. M., Sonneveld, P., Plesner, T., Stevens-Kroef, M., van der Holt, B., Zweegman, S., Waage, A., Klein, S., Sinnige, H., Mellqvist, U-H., Abildgaard, N., Durian, M. F., Hansson, M., Levin, M-D., Leijs, M. B., Szatkowski, D. L., Haukås, E., Salomo, M., Bos, G., Visser-Wisselaar, H. & 11 flere, van der Velden, A., Deenik, W., Gruber, A., Coenen, J. L. L. M., Tanis, B., Brouwer, R., Westerman, M., van der Hem, K., Mattijssen, V., Gimsing, P. & Van De Donk, N. WCJ., 10. dec. 2017.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Monocytes and granulocytes reduce CD38 expression levels on myeloma cells in patients treated with daratumumab

Krejcik, J., Frerichs, K. A., Nijhof, I. S., van Kessel, B., van Velzen, J., Bloem, A. C., Broekmans, M., Zweegman, S., van Meerloo, J., Musters, R. J., Poddighe, P., Groen, R., Chiu, C., Plesner, T., Lokhorst, H. M., Sasser, A. K., Mutis, T. & van de Donk, N. W. C. J., 2017, I : Clinical Cancer Research. 23, 24, s. 7498-7511

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

daratumumab
Membrane Proteins
Cell Membrane
In Vitro Techniques

NaF-PET/CT in multiple myeloma: assessing bone remodeling at baseline in newly diagnosed myeloma patients compared to a healthy control group

Østergaard, B., Zadeh, M., Raynor, W., Taghvaei, R., Nielsen, A. L., Asmussen, J. T., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 2017, I : European Journal of Nuclear Medicine and Molecular Imaging. 44, 2 Suppl., s. 484-485 EP-0128.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

NaF-PET/CT in multiple myeloma: assessing bone remodeling at baseline in newly diagnosed myeloma patients compared to a healthy control group

Østergaard, B., Zadeh, M., Raynor, W., Taghvaei, R., Nielsen, A. L., Holdgaard, P. C., Asmussen, J. T., Plesner, T., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 2017, I : European Journal of Nuclear Medicine and Molecular Imaging. 44, Suppl. 2, s. 484 1 s., EP-0128.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskning

Quality of life with melphalan/prednisone plus either thalidomide (MPT-T) or lenalidomide (MPR-R) in non-transplant eligible newly diagnosed multiple myeloma: results of the HOVON87/NMSG18 study

Stege, C. A. M., Kongsgaard Nielsen, L., Witte, B., van der Holt, B., Mellqvist, U-H., Salomo, M., Bos, G., Levin, M-D., Visser-Wisselaar, H., Hansson, M., van der Velden, A., Deenik, W., Gruber, A., Coenen, J., Plesner, T., Klein, S., Tanis, B., Szatkowski, D. L., Brouwer, R., Westerman, M. & 14 flere, Leys, R., Sinnige, H., Haukås, E., van der Hem, K., Durian, M., Mattijssen, V., Mattijssen, V., Gimsing, P., van de Donk, N., Stevens-Kroef, M., Sonneveld, P., Waage, A., Zweegman, S. & Abildgaard, N., 2017, I : Haematologica. 102, S2, s. 190 1 s., S501.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

62 Downloads (Pure)

Response to: Interference of daratumumab on the serum protein electrophoresis

McCudden, C., Axel, A. E., Slaets, D., Dejoie, T., Clemens, P., Frans, S., Bald, J., Plesner, T., Jacobs, J. F. M., van de Donk, N. W. C. J., Moreau, P., Schecter, J. M., Ahmadi, T. & Sasser, A. K., 2017, I : Clinical Chemistry and Laboratory Medicine. 55, 2, s. e29-e30

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Åben adgang
Fil
80 Downloads (Pure)

Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group

Hillengass, J., Moulopoulos, L. A., Delorme, S., Koutoulidis, V., Mosebach, J., Hielscher, T., Drake, M., Rajkumar, S. V., Oestergaard, B., Abildgaard, N., Hinge, M., Plesner, T., Suehara, Y., Matsue, K., Withofs, N., Caers, J., Waage, A., Goldschmidt, H., Dimopoulos, M. A., Lentzsch, S. & 2 flere, Durie, B. & Terpos, E., 2017, I : Blood Cancer Journal. 7, 8, 6 s., e599.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Surveys and Questionnaires
Skeleton
Positron Emission Tomography Computed Tomography
2016

18F-FDG-PET/CT in Multiple Myeloma: High Intense PET Positive Lesions at Diagnosis Harbor Cytogenetic Adverse Subclones

Østergaard, B., Nielsen, A. L., Møller, H. E. H., Preiss, B. S., Asmussen, J. T., Mortensen, J. R., Plesner, T., Gerke, O., Alavi, A., Høilund-Carlsen, P. F. & Abildgaard, N., 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

18F-FDG-PET/CT in Multiple Myeloma: High Intense PET Positive Lesions at Diagnosis Harbor Cytogenetic Adverse Subclones

Østergaard, B., Nielsen, A. L., Møller, H. E. H., Preiss, B. S., Asmussen, J. T., Mortensen, J. R., Plesner, T., Gerke, O., Alavi, A., Høilund-Carlsen, P. F. & Abildgaard, N., 2016, I : Blood. 128, 22, 3260.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

62 Downloads (Pure)

Baseline bone involvement in multiple myeloma - a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients

Hinge, M., Andersen, K. T., Lund, T., Jørgensen, H. B., Holdgaard, P. C., Ormstrup, T. E., Lange Østergaard, L. & Plesner, T., 2016, I : Haematologica. 101, s. e415-e418

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Åben adgang
Fil
78 Downloads (Pure)

Bone healing in multiple myeloma: A prospective evaluation of the impact of first-line anti-myeloma treatment

Hinge, M., Andersen, K. T., Lund, T., Jørgensen, H. B., Holdgaard, P. C., Ormstrup, T. E., Lange Østergaard, L. & Plesner, T., 2016, I : Haematologica. 101, 10, s. e419-e422

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Åben adgang
Fil

Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma

van de Donk, N. W. C. J., Moreau, P., Plesner, T., Palumbo, A., Gay, F., Laubach, J. P., Malavasi, F., Avet-Loiseau, H., Mateos, M-V., Sonneveld, P., Lokhorst, H. M. & Richardson, P. G., 11. feb. 2016, I : Blood. 127, 6, s. 681-695

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Plasma Cells
Disease-Free Survival
Pharmaceutical Preparations
daratumumab
elotuzumab

Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma

Usmani, S. Z., Weiss, B. M., Plesner, T., Bahlis, N. J., Belch, A., Lonial, S., Lokhorst, H. M., Voorhees, P. M., Richardson, P. G., Chari, A., Sasser, A. K., Axel, A., Feng, H., Uhlar, C. M., Wang, J., Khan, I., Ahmadi, T. & Nahi, H., 23. maj 2016, I : Blood. 128, 1, s. 37-44

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Confidence Intervals
Proteasome Inhibitors
Disease-Free Survival
Safety
daratumumab
321 Downloads (Pure)

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

Dimopoulos, M. A., Oriol, A., Nahi, H., San-Miguel, J., Bahlis, N. J., Usmani, S. Z., Rabin, N., Orlowski, R. Z., Komarnicki, M., Suzuki, K., Plesner, T., Yoon, S-S., Ben Yehuda, D., Richardson, P. G., Goldschmidt, H., Reece, D., Lisby, S., Khokhar, N. Z., O'Rourke, L., Chiu, C. & 5 flere, Qin, X., Guckert, M., Ahmadi, T., Moreau, P. & POLLUX Investigators, 6. okt. 2016, I : The New England Journal of Medicine. 375, 14, s. 1319-1331

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Control Groups
Disease-Free Survival
Residual Neoplasm
Confidence Intervals
Neutropenia

Daratumumab depletes CD38+ immune-regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma

Krejcik, J., Casneuf, T., Nijhof, I. S., Verbist, B., Bald, J., Plesner, T., Syed, K., Liu, K., van de Donk, N. W. C. J., Weiss, B. M., Ahmadi, T., Lokhorst, H. M., Mutis, T. & Sasser, A. K., 24. maj 2016, I : Blood. 128, 3, s. 384-394

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

T-Cell Antigen Receptor
Immunosuppressive Agents
Regulatory B-Lymphocytes
CD4-CD8 Ratio
daratumumab

Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma

Mateos, M-V., Granell, M., Oriol, A., Martínez-López, J., Bladé, J., Hernandez, M. T., Martín, J., Gironella, M., Lynch, M., Bleickardt, E., Paliwal, P., Singhal, A., San-Miguel, J. & Plesner, T., nov. 2016, I : British Journal of Haematology. 175, 3, s. 448-456 9 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Safety
Disease-Free Survival
elotuzumab
Survival Rate
Population

Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

Moreau, P., van de Donk, N. W. C. J., Miguel, J. S., Lokhorst, H., Nahi, H., Ben-Yehuda, D., Cavo, M., Cook, G., Delforge, M., Einsele, H., Zweegman, S., Ludwig, H., Driessen, C., Palumbo, A., Facon, T., Plesner, T., Dimopoulos, M., Sondergeld, P., Sonneveld, P. & Mateos, M-V., jun. 2016, I : Drugs. 76, 9, s. 989-990

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Facilitated subcutaneous immunoglobulin administration (fSCIg): a new treatment option for patients with secondary immune deficiencies

Blau, I-W., Conlon, N., Petermann, R., Nikolov, N. & Plesner, T., jul. 2016, I : Expert Review of Clinical Immunology. 12, 7, s. 705-11

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Hematologic Neoplasms
Survival Rate

FDG-PET/CT in multiple myeloma: Correlation between SUV and standard prognostic scoring system in multiple myeloma

Østergaard, B., Nielsen, A. L., Gerke, O., Mortensen, J. R., Asmussen, J. T., Plesner, T., Ormstrup, T., Holdgaard, P. C., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 2016, I : European Journal of Nuclear Medicine and Molecular Imaging. 43, 1 Suppl. 1, s. S438 1 s., EP559.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

FDG-PET/CT in multiple myeloma: Correlation between SUV and standard prognostic scoring system in multiple myeloma

Østergaard, B., Nielsen, A. L., Gerke, O., Mortensen, J. R., Asmussen, J. T., Plesner, T., Ormstrup, TE., Holdgaard, P. C., Abildgaard, N., Alavi, A. & Høilund-Carlsen, P. F., 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Findings of Whole Body Computed Tomography Compared to Conventional Skeletal Survey in Patients with Monoclonal Plasma Cell Disorders: a Study of the International Myeloma Working Group

Hillengass, J., Monopoulos, L. A., Delorme, S., Koutoulidis, V., Hielscher, T., Engelhart, J., Drake, M. T., Rajkumar, V., Østergaard, B., Abildgaard, N., Hinge, M., Plesner, T., Suehara, Y., Matsue, K., Caers, J., Withofs, N., Dimopoulos1, M., Goldschmidt, H., Lentzsch, S., Durie, B. G. & 1 flere, Terpos, E., 2016, I : Blood. 128, 22, 4468.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Findings of Whole Body Computed Tomography Compared to Conventional Skeletal Survey in Patients with Monoclonal Plasma Cell Disorders – a Study of the International Myeloma Working Group

Hillengass, J., Monopoulos, L. A., Delorme, S., Koutoulidis, V., Hielscher, T., Engelhart, J., Drake, M. T., Rajkumar, V., Østergaard, B., Abildgaard, N., Hinge, M., Plesner, T., Suehara, Y. S., Matsue, K., Caers, J., Withofs, N., Dimopoulos1, M., Goldschmidt, H., Lentzsch, S., Durie, B. G. & 1 flere, Terpos, E., 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial

Eichhorst, B., Fink, A-M., Bahlo, J., Busch, R., Kovacs, G., Maurer, C., Lange, E., Köppler, H., Kiehl, M., Sökler, M., Schlag, R., Vehling-Kaiser, U., Köchling, G., Plöger, C., Gregor, M., Plesner, T., Trneny, M., Fischer, K., Döhner, H., Kneba, M. & 7 flere, Wendtner, C-M., Klapper, W., Kreuzer, K-A., Stilgenbauer, S., Böttcher, S., Hallek, M. & The German CLL Study group (GCLLSG), 20. maj 2016, I : The Lancet Oncology. 17, 7, s. 928-942

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

B-Cell Chronic Lymphocytic Leukemia
diaziquone
Disease-Free Survival
Poisons
fludarabine

Improvement of overall survival in Danish Multiple Myeloma patients after 2008: A population-based study from the Danish National Multiple Myeloma Registry

Abildgaard, N., Vangsted, A., Gregersen, H., Niels Frost, A., Pedersen, R. S., Plesner, T., Pedersen, P. T., Frederiksen, M., Frølund, U., Helleberg, C., Salomo, M., Holmström, M., Klausen, T. W. & Gimsing, P., 2016, European Hematology Association 21st Abstract book. European Hematology Association, 132846

Publikation: Bidrag til bog/antologi/rapport/konference-proceedingKonferenceabstrakt i proceedingsForskning

Improvement of overall survival in Danish Multiple Myeloma patients after 2008; a population-based study from the Danish National Multiple Myeloma Registry

Abildgaard, N., Vangsted, A., Gregersen, H., Niels Frost, A., Pedersen, R. S., Plesner, T., Trøllund Pedersen, P., Frederiksen, M., Frølund, U., Helleberg, C., Salomo, M., Holmström, M., Klausen, T. W. & Gimsing, P., 9. jun. 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma

Zweegman, S., van der Holt, B., Mellqvist, U-H., Salomo, M., Bos, G. M. J., Levin, M-D., Visser-Wisselaar, H., Hansson, M., van der Velden, A. W. G., Deenik, W., Gruber, A., Coenen, J. L. L. M., Plesner, T., Klein, S. K., Tanis, B. C., Szatkowski, D. L., Brouwer, R. E., Westerman, M., Leys, M. R. B. L., Sinnige, H. A. M. & 8 flere, Haukås, E., van der Hem, K. G., Durian, M. F., Mattijssen, E. V. J. M., van de Donk, N. W. C. J., Stevens-Kroef, M. J. P. L., Sonneveld, P. & Waage, A., 3. mar. 2016, I : Blood. 127, 9, s. 1109-16

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Melphalan
Prednisone
Confidence Intervals
Disease-Free Survival
Maintenance
106 Downloads (Pure)

Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference

McCudden, C., Axel, A. E., Slaets, D., Dejoie, T., Clemens, P. L., Frans, S., Bald, J., Plesner, T., Jacobs, J. F. M., van de Donk, N. W. C. J., Moreau, P., Schecter, J. M., Ahmadi, T. & Sasser, A. K., 1. jun. 2016, I : Clinical Chemistry and Laboratory Medicine. 54, 6, s. 1095-104

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Monoclonal Antibodies
Electrophoresis
Monitoring
Assays
daratumumab